Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
LungLife AI, Inc., often known as LungLife AI, is a pioneering entity within the pharmaceutical preparation manufacturing industry, headquartered in San Antonio, Texas, US. With over a decade of heritage, having previously operated as Cynvenio Biosystems, Inc., the company specialises in advanced diagnostic solutions.
At the core of LungLife AI's offerings is LungLBâ„¢, an innovative, AI-powered liquid biopsy test for early lung cancer detection. This cutting-edge diagnostic leverages sophisticated artificial intelligence and genomics, providing a minimally invasive and highly accurate method to identify cancer in its nascent stages.
LungLife AI is committed to transforming patient outcomes by delivering superior medical technology and diagnostic preparations. Their distinctive approach positions them as a key innovator, driving significant advancements in the field of early cancer diagnostics and precision oncology.
-19 vs industry average
LungLife AI, Inc.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
LungLife AI, Inc., a US-based pharmaceutical preparation manufacturer, reported approximately 686,600 kg CO2e in combined Scope 1 and Scope 2 emissions for 2022. This total includes 404,000 kg CO2e from Scope 1 emissions and 282,600 kg CO2e from Scope 2 emissions. In 2021, the company disclosed Scope 1 emissions of approximately 533,000,000 kg CO2e, with no Scope 2 or Scope 3 data available for that year. LungLife AI has not publicly announced specific carbon reduction targets or commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or The Climate Pledge. The company's emissions data is directly reported by LungLife AI, Inc. and is not cascaded from a parent organisation.
No climate goals have been disclosed for LungLife AI, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more